131
Views
13
CrossRef citations to date
0
Altmetric
Research Reports

HRQoL of European children and adolescents with short stature as assessed with generic (KIDSCREEN) and chronic-generic (DISABKIDS) instruments

, , , , &
Pages 817-827 | Published online: 09 Jan 2014

References

  • Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 7(1), 79–92 (2004).
  • Ravens-Sieberer U, Ellert U, Erhart M. Gesundheitsbezogene lebensqualitat von kindern und jugendlichen in Deutschland. Eine normstichprobe fur Deutschland aus dem kinder- und jugendgesundheitssurvey (KIGGS). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 50(5-6), 810–818 (2007).
  • World Health Organization. Measurement of quality of life in children: report of WHO/ IACAPAP working party. London, UK 3–4 June (1993).
  • Bullinger M, Schmidt S, Petersen C, Erhart M, Ravens-Sieberer U. Methodische herausforderungen und potentiale der evaluation gesundheitsbezogener lebensqualitat fur kinder mit chronischen erkrankungen im medizinischen versorgungssystem. Medizinische klinik 102(9), 734–745 (2007).
  • Brütt AL, Sandberg DE, Chaplin J et al. Assessment of health-related quality of life and patient satisfaction in children and adolescents with growth hormone deficiency or idiopathic short stature - part 1: a critical evaluation of available tools. Horm. Res. 72(2), 65–73 (2009).
  • Bullinger M, Koltowska-Haggstrom M, Sandberg D et al. Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature - part 2: available results and future directions. Horm. Res. 72(2), 74–81 (2009).
  • Richmond EJ, Rogol AD. Growth hormone deficiency in children. Pituitary 11(2), 115–120 (2008).
  • GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J. Clin. Endocrinol. Metab.. 85(11), 3990–3993 (2000).
  • Cohen P, Rogol AD, Deal CL et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the growth hormone research society, the lawson wilkins pediatric endocrine society, and the european society for paediatric endocrinology workshop. J. Clin. Endocrinol. Metab. 93(11), 4210–4217 (2008).
  • Batty GD, Shipley MJ, Gunnell D et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ. Hum. Biol. 7(2), 137–152 (2009).
  • Peck MN, Lundberg O. Short stature as an effect of economic and social conditions in childhood. Soc. Sci. Med. 41(5), 733–738 (1995).
  • Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency. J. Pediatr. 25(1), 29–35 (1994).
  • Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm. Res. 45(Suppl. 2), 64–66 (1996).
  • Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm. IGF Res.18(2), 89–110 (2008).
  • Tanaka T, Cohen PE., Clayton P, Laron ZL., Hintz RC., Sizonenko P. Diagnosis and management of growth hormone deficiency in childhood and adolescence – Part 2: Growth hormone treatment in growth hormone deficient children. Growth Horm. IGF Res. 12(5), 323–341 (2002).
  • Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P. Idiopathic short stature: management and growth hormone treatment. Growth Horm. IGF Res., 18(2), 111–135 (2008).
  • Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents (Review). Cochrane Database Syst. Rev. 18(3), 1–30 (2007).
  • Sandberg DE, Voss LD. The psychosocial consequences of short stature: a review of the evidence. Best Pract. Res. Clin. Endocrinol. Metab. 6(3), 449–463 (2002).
  • Voss LD, Mulligan J. Bullying in school: are short pupils at risk? Questionnaire study in a cohort. Br. Med. J. 320(7235), 612–613 (2000).
  • Sandberg DE, Colsman M. Growth hormone treatment of short stature: status of the quality of life rationale. Horm. Res. 63(6), 275–283 (2005).
  • Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G. Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatrica 96(5), 715–719 (2007).
  • Sheppard L, Eiser C, Davies HA et al. The effects of growth hormone treatment on health-related quality of life in children. Horm. Res. 65(5), 243–249 (2006).
  • Wheeler PG, Bresnahan K, Shephard BA, Lau J, Balk EM. Short stature and functional impairment: a systematic review. Arch. Dis. Childhood 158(3), 236–243 (2004).
  • Ross JL, Sandberg DE, Rose SR et al. Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J. Clin. Endocrinol. Metab. 89(10), 4873–4878 (2004).
  • Theunissen NC, Kamp GA, Koopman HM, Zwinderman KA, Vogels T, Wit JM. Quality of life and self-esteem in children treated for idiopathic short stature. J. Pediatr. 140(5), 507–515 (2002).
  • Rekers-Mombarg LTM, Busschbach JVV, Massa GG, Dicke J, Wit JM, Dutch Growth Hormone Working Group. Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Acta Paediatrica 87(8), 865–870 (1998).
  • Leiberman E, Pilpel D, Carel CA, Levi E, Zadik Z. Coping and satisfaction with growth hormone treatment among short-stature children. Horm. Res. 40(4), 128–135 (1993).
  • Visser-van Balen H, Sinnema G, Geenen R. Growing up with idiopathic short stature: psychosocial development and hormone treatment: a critical review. Arch. Dis. Childhood 91(5), 433–439 (2006).
  • Guyatt GH. A taxonomy of health status instruments. J. Rheumatol. 22(6), 1188–1190 (1995).
  • Bullinger M. Health related quality of life and subjective health: Overview of the status of research for new evaluation criteria in medicine. Psychother. Psychosom. Med. Psychol. 47(3-4), 76–91 (1997).
  • Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparitive responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol. 56, 52–60 (2003).
  • Holden EW, Chmielewski D, Nelson CC, Kager VA. Controlling for general and disease-specific effects in child and family adjustment to chronic childhood illness. J. Pediatr. Psychol. 22(1), 15–27 (1997).
  • Bullinger M, Quitmann J, Power M et al. Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument. Health Qual Life Outcomes 11, 76 (2013).
  • The KIDSCREEN Group Europe. The KIDSCREEN questionnaires: Quality of life for children and adolescents - Handbook, Pabst Science Publishers, Lengerich (2006).
  • The DISABKIDS Group Europe. The DISABKIDS Questionnaires: Quality of Life Questionnaires for Children With Chronic Conditions – Handbook. Pabst Science Publishers, Lengerich (2006).
  • Field A. Discovering Statistics Using SPSS (3rd Edition), SAGE Publications, London, UK (2009).
  • Cohen J. Statistical power analysis for the behavioral sciences, Lawrence Erlbaum Associates Inc., Hillsdale NJ, USA (1988).
  • Sneeuw KC, Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J. Clin. Epidemiol. 55, 1130–1143 (2002).
  • Geisler A, Lass N, Reinsch N et al. Quality of life in children and adolescents with growth hormone deficiency: association with growth hormone treatment. Horm. Res. Paediatr. 78(2), 94–99 (2012).
  • Stephen MD, Varni JW, Limbers CAet al. Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naive, growth-hormone-treated, and healthy samples. Eur. J. Pediatr. 170(3), 351–358 (2011).
  • Takeda A, Cooper K, Bird A et al. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol. Assess. 14(42), 1–209 (2010).
  • Gustke M, Kosiol D, Bauer CP, Baumann A, Stachow R, Farin E. Die fragebögen Disabkids und Kidscreen - vergleich der änderungssensitivität bei der erfassung gesundheitsbezogener lebensqualität von kindern und jugendlichen. Zeitschrift für Medizinische Psychologie 20(2), 51–59 (2011).
  • Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual. Life Res. 17, 895–913 (2008).
  • Sattoe J, van Staa A, Moll H; On Your Own Feet Research Group.The proxy problem anatomized: child-parent disagreement in health related quality of life reports of chronically ill adolescents. Health Qual. Life Outcomes 10, 10–22 (2012).
  • White-Koning M, Arnaud C, Dickinson HO et al. Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy. Pediatrics 120, e804–e814 (2007).
  • Gerharz EW, Eiser C, Woodhouse CRJ. Current approaches to assessing the quality of life in children and adolescents. BJU Int. 91, 150–154 (2003).
  • Christensen T, Buckland A, Bentley A, Djurhuus C, Baker-Searle R. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age. Clin. Therapeutics, 32(6), 1068–1082 (2010).
  • Durand-Zaleski I. Developments in idiopathic short stature: cost versus allocation of resources. Horm. Res. Paediatr. 76(3), 33–35 (2011).
  • Radcliffe DJ, Pliskin JS, Silvers JB, Cuttler L. Growth hormone therapy and quality of life in adults and children. Pharmacoeconomics 22(8), 499–524 (2004).
  • Rosenfeld RG. Pharmacological interventions for short stature: pros and cons. Nestlé Nutr. Inst. Workshop Ser. 71, 207–217 (2013).
  • Ranke MB. Treatment of children and adolescents with idiopathic short stature. Nat. Rev. Endocrinol. 9(6), 325–340 (2013).
  • Noeker M. Management of idiopathic short stature: psychological endpoints, assessment strategies and cognitive-behavioral intervention. Hormone Res. 71(Suppl. 1), 75–81 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.